Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) reached a new 52-week low on Monday . The stock traded as low as GBX 14 ($0.18) and last traded at GBX 18 ($0.23), with a volume of 368579 shares traded. The stock had previously closed at GBX 28 ($0.36).
Celadon Pharmaceuticals Stock Performance
The firm has a market cap of £10.47 million, a PE ratio of -230.00 and a beta of -0.26. The company has a 50 day simple moving average of GBX 30.14 and a 200-day simple moving average of GBX 54.52. The company has a debt-to-equity ratio of 194.82, a current ratio of 1.92 and a quick ratio of 6.97.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- What Do S&P 500 Stocks Tell Investors About the Market?
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
